Immuron (IMRN) Research & Development (2016 - 2024)

Immuron's Research & Development history runs 9 years deep, the most recent figure standing at -$1296.2 billion for Q4 2024.

• On a quarterly basis, Research & Development fell 48857378.76% year-over-year to -$1296.2 billion in Q4 2024; TTM through Dec 2024 was -$1296.2 billion, a 31922477.45% decrease from a year earlier, with the FY2025 full-year figure at $2.3 million, down 33.87% from the prior year.
• Research & Development eased to -$1296.2 billion in Q4 2024 per IMRN's latest filing, from -$2.7 million in the prior quarter.
• Across five years, Research & Development topped out at $358281.0 in Q4 2020 and bottomed at -$1296.2 billion in Q4 2024.
• The 5-year median for Research & Development is -$834870.8 (2022), against an average of -$216.0 billion.
• Across the five-year window, Research & Development dropped 26.8% in 2021 and sank 48857378.76% in 2024, its largest moves.
• Year by year, Research & Development stood at $358281.0 in 2020, then fell by 26.8% to $262268.2 in 2021, then slumped by 680.18% to -$1.5 million in 2022, then plunged by 74.36% to -$2.7 million in 2023, then sank by 48857378.76% to -$1296.2 billion in 2024.
• Per Business Quant, the three latest IMRN Research & Development figures stand at -$1296.2 billion (Q4 2024), -$2.7 million (Q4 2023), and -$148106.7 (Q2 2023).